Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

NCT00002676 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: carmustine
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: methotrexate
DRUG: vincristine sulfate
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]